In a market searching for asymmetric upside, ENDRA Life Sciences (NASDAQ. NDRA) is quietly building one of the more compelling dual-engine growth narratives in the small-cap space. The company sits at the intersection of two powerful trends ... (NYSE ... DNN).
DNN) saw its shares climb by an impressive 4.25% today, reflecting a palpable resurgence of investor interest in the uranium sector ... DNN) itself is a primary beneficiary ... DNN) itself will likely focus ...